Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials
FDA Law
MAY 4, 2023
This draft guidance builds on recommendations that FDA initially developed early in 2020, in response to the COVID-19 challenges (see our blog post on these recommendations here ). Study visits can be conducted using telehealth visits if in-person interaction is not necessary. Trial personnel can also be sent to participant’s homes.
Let's personalize your content